Cytoki Pharma ApS

CVR40594132Under likvidation

Core data

Name
Cytoki Pharma ApS
Address
Vandtårnsvej 77, 2860, Søborg
Founded
Jun 12, 2019
3 / 3Mar 2026
Locations (P-units)
1View locations
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of Cytoki Pharma ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Financials

Company financials
Reporting period
2025DKK
Gross profit
-42,198,706
Operating profit
-49,461,173
Profit before tax
-49,300,007
Net income
-43,800,007
Total assets
17,962,975
Equity
13,473,548
Avg. employees
4
2019–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
**@cytokipharma.comShow full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Anders HagstrømRoles
Likvidator
TitlesLIKVIDATOR
Henrik Sindal JensenRoles
Reelle ejere
TitlesReel ejer
Katja BarnkobRoles
Reelle ejere
TitlesReel ejer
Michael KjærRoles
Reelle ejere
TitlesReel ejer
Mikkel Helmer NielsenRoles
Reelle ejere
TitlesReel ejer
Morten Egholm AagaardRoles
Reelle ejere
TitlesReel ejer
Morten HummelmoseRoles
Reelle ejere
TitlesReel ejer
Susanne Krüger KjærRoles
Reelle ejere
TitlesReel ejer
Svend AndersenRoles
Reelle ejere
TitlesReel ejer
Søren SkouRoles
Reelle ejere
TitlesReel ejer
Thomas Mears WergeRoles
Reelle ejere
TitlesReel ejer

Auditor

PricewaterhouseCoopers Statsautoriseret RevisionspartnerselskabAuditorMads LundemannRoleState Authorised Public AccountantFromApr 8, 2026
PricewaterhouseCoopersStatsautoriseret RevisionspartnerselskabAuditorFlemming EghoffRoleState Authorised Public AccountantFromApr 8, 2026
Ownership25–33.32 %Voting rights25 %FromApr 28, 2021

Unknown Other Participant

Ownership20–24.99 %Voting rights20 %FromMay 8, 2024

Unknown Other Participant

Ownership15–19.99 %Voting rights15 %FromMay 8, 2024
Ownership10–14.99 %Voting rights10 %FromDec 19, 2022

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromMay 8, 2024
Ownership5–9.99 %Voting rights5 %FromJun 21, 2021

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromJun 21, 2021

Beneficial owners

Ownership—Voting rights—FromMar 22, 2022
Ownership—Voting rights—FromMar 22, 2022

Unknown Other Participant

Ownership—Voting rights—FromApr 28, 2021
Ownership—Voting rights—FromApr 28, 2021
Ownership—Voting rights—FromMar 22, 2022
Ownership—Voting rights—FromMar 22, 2022
Ownership—Voting rights—FromMar 12, 2025
Nawal Ouzren🇫🇷

Unknown Other Participant

Ownership—Voting rights—FromMar 12, 2025
Ownership—Voting rights—FromMar 12, 2024
Ownership—Voting rights—FromApr 28, 2021
Ownership—Voting rights—FromApr 28, 2021
Ownership—Voting rights—FromMar 27, 2023

Ultimate owners

LUNDBECKFONDEN
Ownership through
25–33.32 %
🇰🇾NanoDimension III, L.P
Ownership through
Direct
20–24.99 %
🇪🇸YSIOS Biofund III, F.C.R.E
Ownership through
Direct
15–19.99 %
Rasmus Jørgensen
Ownership through
10–14.99 %
🇫🇷FCPI Bio Sante 2018-2019
Ownership through
Direct
5–9.99 %
🇫🇷Health for Life Capital II FPCI - ALPHA Compartment
Ownership through
Direct
5–9.99 %
🇱🇺Health For Life Capital II Prima S.C.A. RAIF
Ownership through
Direct
5–9.99 %

Official sources